ACR-EULAR 原发性干燥综合征分类标准在荷兰前瞻性诊断队列中的验证
在荷兰前瞻性诊断队列中验证 ACR-EULAR 原发性干燥综合征(pSS)分类标准,并与 AECG 和 ACR 标准比较。114 例患者中专家分类 34 例(30%)为 pSS。采用唇腺活检时 ACR-EULAR 与专家分类绝对一致率 87%(κ=0.73),敏感度 97%、特异度 83%。
要点
- ACR-EULAR 标准与专家分类绝对一致率 87%(κ=0.73),敏感度 97%、特异度 83%。
- ACR-EULAR 与 AECG 标准效度相当,较 ACR 标准敏感度更高但特异度更低。
- 非刺激全唾液流率和 Schirmer 试验判别力差,焦点评分、抗 SSA 滴度和眼染色评分判别力好至优。
核心结论
- ACR-EULAR 标准与专家分类一致性良好,但部分患者可能被误分类为 pSS。
- 非刺激全唾液流率和 Schirmer 试验判别价值差。
- ACR-EULAR 标准与 AECG 标准效度相当,较 ACR 标准敏感度更高但特异度更低。
研究设计与样本
- 荷兰前瞻性诊断队列,连续纳入因怀疑 pSS 转诊的患者 n=129,均接受多学科评估包括唇腺和/或腮腺活检。
- 排除检查不完整者 n=8 和合并相关系统性自身免疫病者 n=7,最终评估 114 例。
- 将 ACR-EULAR 分类与专家分类、AECG 及 ACR 分类比较,并分别用腮腺或唇腺活检结果描述各标准集的效度。
主要发现
- 114 例中专家小组分类 34 例(30%)为 pSS,80 例(70%)为非 pSS。
- 采用唇腺活检结果时,ACR-EULAR 分类与专家分类绝对一致率 87%(κ=0.73),敏感度 97%、特异度 83%。
- 采用腮腺活检结果时 ACR-EULAR 标准表现同样优秀。
- 焦点评分、抗 SSA 滴度和眼染色评分显示好至优的准确度,而非刺激全唾液流率和 Schirmer 试验准确度差。
- ACR-EULAR 与 AECG 标准效度相当;与 ACR 分类相比,ACR-EULAR 分类敏感度更高但特异度更低。
关键数值与推荐
- 采用唇腺活检结果时,ACR-EULAR 与专家分类绝对一致率 87%(κ=0.73),敏感度 97%、特异度 83%。
- 专家小组将 114 例中的 34 例(30%)分类为 pSS、80 例(70%)为非 pSS。
- 焦点评分、抗 SSA 滴度和眼染色评分准确度好至优,非刺激全唾液流率和 Schirmer 试验准确度差。
- ACR-EULAR 与 AECG 标准效度相当,较 ACR 标准敏感度更高但特异度更低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To validate the ACR-EULAR classification criteria for primary SS (pSS), and compare them to the American-European Consensus Group (AECG) and ACR criteria in a Dutch prospective diagnostic cohort. METHODS: Consecutive patients (n = 129) referred for suspicion of pSS underwent a multidisciplinary evaluation, including a labial and/or parotid gland biopsy. Patients with an incomplete work-up (n = 8) or associated systemic auto-immune disease (n = 7) were excluded. The ACR-EULAR classification was compared with expert classification, AECG and ACR classification. Additionally, the accuracy of individual ACR-EULAR items in discriminating pSS from non-pSS was evaluated. The validity of criteria sets was described separately using parotid or labial gland biopsy results for classification. RESULTS: Of the 114 evaluated patients, the expert panel classified 34 (30%) as pSS and 80 (70%) as non-pSS. Using labial gland biopsy results, ACR-EULAR classification showed 87% absolute agreement (κ = 0.73) with expert classification, with a sensitivity of 97% and specificity of 83%. Using the parotid gland biopsy results, the ACR-EULAR criteria performed excellently as well. Focus score, anti-SSA titre and ocular staining score showed good to excellent accuracy, whereas unstimulated whole saliva and Schirmer's test had poor accuracy. The ACR-EULAR and AECG criteria had equal validity. Compared with ACR classification, ACR-EULAR classification showed higher sensitivity but lower specificity. CONCLUSION: The ACR-EULAR criteria showed good agreement with expert classification, but some patients may be misclassified as pSS. Unstimulated whole saliva and Schirmer's test showed poor discriminative value. The ACR-EULAR criteria performed equally to the AECG criteria, and had higher sensitivity but lower specificity than the ACR criteria.
引用
- van Nimwegen JF, van Ginkel MS, Arends S, et al. Validation of the ACR-EULAR criteria for primary Sjögren's syndrome in a Dutch prospective diagnostic cohort. Rheumatology (Oxford). 2018. PMID: 29444331. doi:10.1093/rheumatology/kex495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。